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OBJECTIVES We compared six-month health-related quality of life (HRQL) for high-risk patients with
medically refractory ischemia randomized to percutaneous coronary intervention (PCI) versus
coronary artery bypass graft (CABG) surgery.
BACKGROUND Mortality rates after PCI and CABG surgery are similar. Therefore, differences in HRQL
outcomes may help in the selection of a revascularization procedure.
METHODS Patients were enrolled in a Veterans Affairs multicenter randomized trial comparing PCI
versus CABG for patients with medically refractory ischemia and one or more risk factors for
adverse outcome; 389 of 423 patients (92%) alive six months after randomization completed
an Short Form-36 (SF-36) health status survey. Primary outcomes were the Physical
Component Summary (PCS) and Mental Component Summary (MCS) scores from the
SF-36. Multivariable analyses were used to evaluate whether PCI or CABG surgery was
associated with better PCS or MCS scores after adjusting for over 20 baseline variables.
RESULTS There were no significant differences in either PCS scores (38.7 vs. 37.3 for PCI and CABG,
respectively; p  0.23) or MCS scores (45.5 vs. 46.1, p  0.58) between the treatment arms.
In multivariable models, there remained no difference in HRQL for post-PCI versus
post-CABG patients (for PCS, absolute difference 0.56 standard error of 1.14, p 0.63;
for MCS, absolute difference  1.23  1.12, p  0.27). We had 97% power to detect a
four-point difference in scores, where four to seven points is a clinically important difference.
CONCLUSIONS High-risk patients with medically refractory ischemia randomized to PCI versus CABG
surgery have equivalent six-month HRQL. Therefore, HRQL concerns should not drive
decision-making regarding selection of a revascularization procedure for these
patients. (J Am Coll Cardiol 2003;41:1732–8) © 2003 by the American College of
Cardiology Foundation
Multiple studies have demonstrated equivalent mortality
between percutaneous coronary intervention (PCI) and
coronary artery bypass graft (CABG) surgery (1–9). At the
same time, these investigations have consistently shown that
patients who undergo PCI are much more likely to have
recurrent angina and to require repeat procedures. Because
angina is an important determinant of health-related quality
of life (HRQL) (10–12), PCI patients could have worse
HRQL outcomes compared with CABG patients despite
equivalent mortality. On the other hand, CABG surgery is
more invasive, and concerns remain about the impact of
cardiopulmonary bypass on neurocognitive outcomes
(13,14). Consequently, it is important to compare HRQL
outcomes after PCI versus CABG surgery, because any
significant differences may influence the choice of revascu-
larization procedure.
Few randomized trials have included HRQL compari-
sons after PCI versus CABG surgery, and these studies have
had conflicting results (15–19). Furthermore, HRQL out-
comes have not been evaluated in high-risk patients, be-
cause they have been excluded from randomized trials
(1–9,13). Specifically, previous trials have excluded patients
with prior heart surgery, very recent myocardial infarction
(MI), and severe left ventricular dysfunction.
The Department of Veterans Affairs (VA) Angina With
Extremely Serious Operative Mortality (AWESOME) study
was specifically designed to compare outcomes after random-
ization to PCI versus CABG surgery for patients with medi-
cally refractory angina who were at high risk for adverse
outcome (20). The primary clinical results of the AWESOME
study demonstrated equivalent mortality between the PCI and
CABG arms (21). The purpose of this study was to compare
six-month HRQL outcomes after randomization to PCI
versus CABG surgery in the AWESOME trial.
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METHODS
Study population. The AWESOME randomized con-
trolled trial was conducted at 16 VA medical centers
between February 1995 and March 2000. The methods and
primary clinical outcomes (mortality, recurrent unstable
angina, and repeat revascularization procedure outcomes)
have previously been published (20,21). To be enrolled in
the AWESOME study, patients had to have evidence of
myocardial ischemia refractory to medical management and
one or more risk factors for adverse outcome with CABG
surgery, including prior open-heart surgery, age 70 years,
left ventricular ejection fraction 0.35, MI within seven
days, or need for an intra-aortic balloon pump (IABP) to
stabilize blood pressure. Eligible patients underwent coro-
nary angiography. Patients with the following criteria were
excluded from the study: single-vessel circumflex disease,
unprotected left main stenosis 50%, no graftable or
dilatable vessels, and/or comorbidity likely to limit patient
life expectancy to 6 months. Patients with coronary
anatomy deemed acceptable for randomization between
PCI and CABG surgery by both the participating cardio-
thoracic surgeon and interventional cardiologist were ap-
proached for informed consent to participate in the trial.
Human subject approval was obtained from the Hines
Veterans Affairs Cooperative Studies Program Coordinat-
ing Center Human Rights Committee and the institutional
review boards at all participating sites.
Of the 2,431 patients who met initial eligibility criteria
for the study before coronary angiography, 781(32%) had
coronary anatomy deemed acceptable for randomization to
either revascularization method. These patients were ap-
proached for informed consent, and 454 (58%) consented to
participate in the study. All patients enrolled in the study
who were alive six months after randomization were sent a
Short Form-36 (SF-36) health status survey. If patients did
not respond to the initial survey, a second mailed survey was
sent. If patients failed to return the mailed surveys, tele-
phone administration of the survey was attempted. Of the
454 randomized patients, 423 (93.2%) were alive at six
months, and 389 (92%) of these patients completed an
SF-36 health status survey. A similar proportion of patients
from the PCI group (n  193, 91.5%) and CABG surgery
group (n 196, 92.5%) completed the SF-36. A six-month
HRQL assessment was chosen because there was a reason-
able expectation of full recovery from both procedures (e.g.,
it coincides with the primary timeframe for restenosis after
PCI), and because numerous prior studies of HRQL after
PCI and CABG surgery have assessed this time period
(10,22–25).
Variables. The outcome variables for this study were from
the six-month SF-36 health status survey. This survey
contains 36 questions that are used to measure eight health
constructs including physical functioning, physical role
functioning, bodily pain, general health, vitality, social
functioning, emotional role functioning, and mental health
(26,27). For example, with regard to physical health, pa-
tients are asked to rate how much their health limits their
ability to do a series of activities ranging from bathing to
running. As another example related to mental health,
patients are asked to rate how much trouble they have had
with work or other regular daily activities due to emotional
problems such as feeling depressed or anxious. The com-
plete SF-36 can be viewed at www.sf36.com.
The Physical Component Summary (PCS) and Mental
Component Summary (MCS) scores, reflecting overall
physical and mental health status, respectively, are derived
from the eight original scales of the SF-36 (Fig. 1). The
summary scores are standardized to the general U.S. popu-
lation (mean  SD; 50  10), allowing easier norm-based
interpretation. Scoring of the SF-36 for the original eight
scales and the PCS and MCS summary scores followed the
methods of Ware et al. (27).
Abbreviations and Acronyms
AWESOME  Department of Veterans Affairs Angina
With Extremely Serious Operative
Mortality study
BARI  Bypass Angioplasty Revascularization
Investigation trial
CABG  coronary artery bypass graft
CABRI  Coronary Angioplasty versus Bypass
Revascularization Investigation trial
EAST  Emory Angioplasty Versus Surgery trial
HRQL  health-related quality of life
IABP  intra-aortic balloon pump
MCS  Mental Component Summary
MI  myocardial infarction
PCI  percutaneous coronary intervention
PCS  Physical Component Summary
RITA  Randomized Intervention Treatment of
Angina study
SF-36  Short Form-36
VA  Veterans Affairs
Figure 1. The relationship between the eight original scales of the Short
Form-36 (SF-36) and the two summary scores. Figure adapted from Ware
and Kosinski (27); reproduced with permission; SF-36 Health Survey,
copyright 1988, 2002 by Medical Outcomes Trust and QualityMetric Inc.
All rights reserved; SF-36 is a registered trademark of the Medical
Outcomes Trust.
1733JACC Vol. 41, No. 10, 2003 Rumsfeld et al.
May 21, 2003:1732–8 Quality of Life After PCI and CABG Surgery
The primary predictor variable of interest for this study
was randomization to either PCI or CABG surgery. Other
candidate predictor variables included the wide array of
demographic, cardiac history, and noncardiac history vari-
ables listed in Table 1. There was 5% missing data for all
of the Table 1 variables except current smoking (27%) and
peripheral vascular disease (6%), and there were no differ-
ences in missing data between the PCI and CABG surgery
cohorts.
Statistical analyses. The objective of this study was to
determine whether patients randomized to PCI versus
CABG surgery were at risk for worse six-month physical
and/or mental health status outcomes. Primary analyses
were conducted with the PCS and MCS scores from the
SF-36 as outcome variables. Secondary analyses were con-
ducted using the original eight scales of the SF-36 as
outcome variables.
Baseline characteristics of the patients randomized to
PCI versus CABG surgery were compared using t tests for
continuous variables and chi-square tests for categorical
variables. We also compared baseline characteristics be-
tween patients who did and did not complete the six-month
SF-36 survey. The bivariate relationship between revascu-
larization assignment (PCI vs. CABG) and the SF-36
outcome variables was evaluated using least-squares linear
regression. Then, a series of multiple linear regression
models were developed to: 1) determine the predictors of
PCS and MCS scores for the overall study population, and
2) assess PCI versus CABG surgery as a predictor of
HRQL, adjusted for baseline patient characteristics.
Regression models were developed by applying backward
selection to the Table 1 variables (p  0.05 to remain in
model), and then adding the revascularization variable (PCI
vs. CABG) to the selected models. Unselected regression
models were also developed including all of the variables
listed in Table 1 as well as the revascularization assignment
variable (PCI vs. CABG) to maximally control for con-
founding. The results of the selected and unselected models
were similar, and the parameter estimates from the selected
models are presented in this article.
Subgroup analyses were performed to compare HRQL
outcomes between the PCI and CABG cohorts within the
Table 1. Baseline Characteristics of the Study Population by Treatment Group
Variables
CABG
(n  196)
PCI
(n  193) p Value
Demographic
Age, mean (SD), yrs 67.3 (9.1) 67.6 (9.3) 0.80
Age 70 yrs 52.6 52.3 0.97
BSA mean (SD), m2 2.05 (0.22) 2.06 (0.22) 0.94
Male gender 98.5 98.9 0.67
Race/ethnicity 0.66
Caucasian 88.2 85.3
African American 5.6 5.8
Hispanic 5.6 7.4
Other 0.5 1.6
Cardiac history
Prior PCI 21.7 18.1 0.38
Prior CABG surgery 30.1 29.0 0.81
Prior cardiac arrest 2.1 2.2 0.97
MI within 7 days 30.6 34.2 0.45
LVEF 0.35 21.9 17.1 0.23
IABP required to stabilize blood pressure 0.5 2.1 0.17
SBP mean (SD), mm Hg 129.0 (19.6) 127.9 (21.0) 0.61
DBP mean (SD), mm Hg 71.1 (11.5) 71.0 (11.0) 0.96
Pulse, mean (SD), beats/min 68.8 (11.30) 67.0 (13.2) 0.17
Normal sinus rhythm on ECG 91.9 86.1 0.09
Q waves on ECG 33.5 36.7 0.55
New ST- or T-wave changes on ECG 52.1 49.7 0.67
Intravenous nitroglycerin 28.6 32.1 0.45
Beta-blockers 78.9 78.9 0.99
Non-cardiac history
Serum creatinine, mean (SD), mg/dl 1.27 (0.88) 1.17 (0.35) 0.18
Cerebrovascular disease 19.9 15.5 0.26
Peripheral vascular disease 19.5 12.4 0.07
Chronic obstructive pulmonary disease 25.8 18.6 0.09
Diabetes mellitus 33.9 27.9 0.21
Current smoker 32.6 37.7 0.38
Hypertension 71.9 67.4 0.33
All values expressed as percentages unless otherwise noted.
BSA  body surface area; CABG  coronary artery bypass graft; DBP  diastolic blood pressure; ECG  electrocardio-
gram; IABP  intra-aortic balloon pump; LVEF  left ventricular ejection fraction; MI  myocardial infarction; PCI 
percutaneous coronary intervention; SBP  systolic blood pressure.
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following patient groups: age 70 years versus 70 years,
Caucasian versus non-Caucasian race, and stratified by prior
CABG surgery, MI within seven days, diabetes, and chronic
obstructive pulmonary disease. These subgroups were cho-
sen because these factors have been associated with HRQL
in other studies (28,29).
All analyses were conducted with an intention-to-treat
approach based on initial randomization, and there was only
one crossover in the PCI cohort and six crossovers in the
CABG surgery cohort in the six-month follow-up period.
All analyses were done using SAS version 8.02 (SAS
Institute, Cary, North Carolina). Power calculations were
done using PASS software 2000 (NCSS Statistical Soft-
ware, Kaysville, Utah). We had 82% power to detect a
three-point difference, and 97% power to detect a four-
point difference, in PCS and MCS scores between the PCI
and CABG cohorts, where four to seven points is consid-
ered a minimal clinically important difference (27,30).
RESULTS
Baseline characteristics of the study population are com-
pared between the PCI and CABG surgery cohorts in Table
1. There were no significant differences in demographics,
prior cardiac history, and noncardiac history between pa-
tients assigned to PCI versus CABG surgery. Overall, the
mean age of the study population was 67.4 years, and over
one-half of the patients were 70 years old. Approximately
30% of the patients had a history of prior CABG surgery,
32% of the patients had experienced an MI within seven
days, 20% had a left ventricular ejection fraction0.35, and
1.3% required an IABP before randomization. There was a
significant burden of comorbidity, including diabetes (31%),
chronic obstructive pulmonary disease (22%), and peripheral
vascular disease (16%). There were no significant differences
in baseline characteristics between those patients that did or
did not complete the six-month SF-36 survey except for
IABP (1.3% for responders, 5.9% for nonresponders, p 
0.04).
Unadjusted physical and mental health status outcomes
are compared between patients assigned to PCI versus
CABG surgery in Table 2 and Figures 2 and 3. There were
no significant differences in physical or mental health status
outcomes between the PCI and CABG cohorts. In sub-
group analyses, there were no significant differences in PCS
or MCS scores for the age, race, prior CABG surgery,
recent MI, diabetes, and chronic obstructive pulmonary
disease subgroups. In diabetics, there was a trend toward
lower PCS scores for patients assigned to CABG surgery
versus PCI (34.7 vs. 38.1, p  0.10), but no difference in
MCS scores (46.0 vs. 46.5, p  0.83).
In multivariable analyses, significant predictors of worse
six-month physical health status (PCS scores) for the total
study population were chronic obstructive pulmonary dis-
ease, diabetes, and elevated serum creatinine (Table 3).
Significant predictors of worse six-month mental health
status (MCS scores) were current smoking and a history of
hypertension. Treatment with a beta-blocker was associated
with better six-month mental health status.
Revascularization assignment (PCI vs. CABG) was not
significantly associated with any of the SF-36 outcome
variables in the multivariable models. After adjustment for
Figure 2. Comparison of Short Form-36 physical health scale scores
between patients randomized to percutaneous coronary intervention and
coronary artery bypass graft surgery. BP  bodily pain; GH  general
health; PCS Physical Component Summary; PF physical functioning;
PRF physical role functioning. Solid bars coronary artery bypass graft
surgery; hatched bars  percutaneous coronary intervention.
Table 2. Comparison of Unadjusted Physical and Mental Health Status Outcomes From the
SF-36
SF-36 Scale
Mean CABG Cohort Score
(95% Confidence Limit)
Mean PCI Cohort Score
(95% Confidence Limit) p Value
Physical health outcomes
Physical Component Summary 37.3 (35.8–38.9) 38.7 (37.1–40.2) 0.23
Physical functioning 53.7 (49.6–57.9) 56.7 (52.8–60.6) 0.30
Physical role functioning 40.1 (34.0–46.2) 43.8 (37.4–50.3) 0.41
Bodily pain 62.7 (59.3–66.1) 64.8 (61.4–68.3) 0.38
General health 47.2 (43.9–50.5) 49.2 (45.9–52.4) 0.40
Mental health outcomes
Mental Component Summary 46.1 (44.7–47.6) 45.5 (44.0–47.1) 0.58
Vitality 46.5 (43.2–49.8) 47.1 (43.8–50.4) 0.80
Social functioning 59.0 (54.8–63.1) 60.2 (56.1–64.3) 0.68
Emotional role functioning 65.8 (60.0–71.6) 62.7 (56.5–68.8) 0.47
Mental health 65.9 (63.0–68.7) 65.5 (62.5–68.5) 0.88
CABG  coronary artery bypass grafting; PCI  percutaneous coronary intervention; SF-36  Short Form-36.
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demographic, cardiac history, and noncardiac history vari-
ables, the absolute difference in PCS scores for post-PCI
versus post-CABG patients was 0.56  standard error of
1.14 (p  0.63), and the absolute difference in MCS scores
was 1.23  standard error of 1.12 (p  0.27).
DISCUSSION
The objective of this study was to compare six-month
HRQL outcomes for high-risk patients with medically
refractory angina who were randomized to PCI versus
CABG surgery. We found equivalent HRQL outcomes for
the post-PCI and post-CABG patients. Similar results were
noted in analyses adjusting for over 20 demographic, car-
diac, and comorbid variables, as well as in subgroup analy-
ses.
This study expands the previous literature by the inclu-
sion of high-risk patients excluded from previous trials,
namely those with prior heart surgery, age 70, ejection
fraction 0.35, MI within seven days, and/or need for
preprocedure IABP. A previous meta-analysis stated that no
firm conclusions could be drawn with regard to outcomes
after PCI versus CABG surgery for high-risk patients
because there was only observational data (31). This study
helps close this gap in the literature.
Multiple previous studies have demonstrated improve-
ments in HRQL from pre- to postprocedure for both PCI
and CABG surgery (10,12,22–25,32), but few studies have
compared HRQL outcomes between the two procedures.
Furthermore, the results of previous randomized trials
comparing HRQL after PCI versus CABG surgery have
been inconsistent. The Coronary Angioplasty versus Bypass
Revascularization Investigation (CABRI) trial found equiv-
alent one-year HRQL outcomes for patients randomized to
PCI versus CABG surgery (15). The Bypass Angioplasty
Revascularization Investigation (BARI) trial found better
physical function for CABG surgery patients compared
with PCI patients in the first three years after revascular-
ization, but HRQL outcomes were equivalent after three
years (16,17). Finally, both the Randomized Intervention
Treatment of Angina (RITA) study and Emory Angio-
plasty Versus Surgery Trial (EAST) found that patients
randomized to PCI had some HRQL impairment com-
pared with those randomized to CABG surgery (18,19).
Therefore, the results of this study are consistent with
both the CABRI and BARI long-term follow-up studies.
The reasons why the results of this study, as well as CABRI
and BARI, differ from the RITA and EAST trials are
unknown. However, the HRQL deficits for PCI patients in
RITA and EAST were directly correlated to recurrent
angina. One may speculate that advances in PCI such as
stents may have reduced post-PCI angina burden. Also,
HRQL assessment varied substantially for each study. For
example, the EAST trial used physician-assigned angina
class as a quality-of-life measure, whereas we used the
SF-36 health status survey to quantify overall physical and
mental health status as reported by the patient.
Interest in evaluating the outcomes of diabetic patients
after coronary revascularization has increased with the
publication of subgroup analysis from the BARI trial and
observational data demonstrating improved survival among
diabetics who undergo CABG surgery compared with PCI
(33,34). In the AWESOME study, survival was not signif-
icantly different for diabetics receiving CABG surgery
versus PCI (35). In our study, diabetes was a predictor of
worse physical health status in our overall study population,
and we found a trend toward worse physical health status in
diabetics assigned to CABG surgery. Thus, it is possible
that the survival benefit in diabetics after CABG surgery
may be partially offset by worse HRQL. Because both the
BARI diabetic substudy and this study evaluated diabetics
in subgroup analyses, and because there have been impor-
tant advances in both CABG surgery (e.g., off-pump
bypass) and PCI (e.g., drug-eluting stents), future studies
simultaneously evaluating both survival and quality of life
after randomization to CABG surgery versus PCI in dia-
betics with multivessel coronary artery disease are war-
ranted.
A strength of this study was the focus on HRQL
Figure 3. Comparison of Short Form-36 mental health scale scores
between patients randomized to percutaneous coronary intervention and
coronary artery bypass graft surgery. ERF  emotional role functioning;
MCSMental Component Summary; MHmental health; SF social
functioning; VT  vitality. Solid bars  coronary artery bypass graft
surgery; hatched bars  percutaneous coronary intervention.
Table 3. Multivariable Risk Models for Physical and Mental
Component Summary Scores for the Overall Study Population*
Variables
Parameter Estimate
(Standard Error) p Value
Physical Component Summary
Chronic obstructive
pulmonary disease
3.67 (1.34) 0.01
Diabetes mellitus 2.95 (1.18) 0.01
Serum creatinine
(per 1 mg/dl increment)
2.28 (0.86) 0.01
Mental Component Summary
Current smoking 3.64 (1.24) 0.01
Hypertension 2.72 (1.18) 0.02
Beta-blockers 3.06 (1.28) 0.02
*Adjusted for the demographic, cardiac history, and noncardiac history variables listed
in Table 1.
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outcomes, which is consistent with the goal of promoting
patient-centeredness to improve the quality of care in the
U.S. as set forth by the Institute of Medicine (36). Also,
many HRQL studies are observational, raising concerns
about comparability of patients and concerns about com-
parison of outcomes. A major strength of this study was the
randomized trial design, supporting comparability of the
PCI and CABG cohorts with regard to both measured and
unmeasured confounders. Additional strengths of this study
included the high survey response rate and the use of a
validated and reliable tool for the assessment of physical and
mental health status (12,26,27). Finally, we had adequate
power to detect clinically important differences between the
PCI and CABG surgery groups.
Study limitations. Potential limitations of this study
should be addressed. First, this clinical trial included a select
group of high-risk VA patients. Results may not be gener-
alizable to lower risk patients or to non-VA settings.
Second, there was only one assessment of HRQL six
months after randomization. Longitudinal assessment
would be ideal to evaluate changes over time and the
trajectory of HRQL outcomes for the PCI and CABG
surgery cohorts. Finally, we only had a general measure of
HRQL, and it would be ideal to evaluate both general and
disease-specific HRQL.
Conclusions. We found that high-risk patients with med-
ically refractory ischemia randomized to PCI versus CABG
surgery have equivalent six-month HRQL outcomes.
Therefore, HRQL concerns should not drive decision-
making regarding selection of a revascularization procedure
for these patients.
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